Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine

Despite the great efforts for better treatment options for diffuse large B-cell lymphoma (DLBCL) (most common form of non-Hodgkin lymphoma, NHL) to treat and prevent relapse, it continues to be a challenge. Here, we present an overview of DLBCL and address the diagnostic assays and molecular techniq...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Lodhi, Niraj, Tun, Moe, Nagpal, Poonam, Inamdar, Arati A., Ayoub, Nehad M., Siyam, Noor, Oton-Gonzalez, Lucia, Gerona, Angela, Morris, Dainelle, Sandhu, Rana, Suh, Kwangsun Stephen
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7646825/
https://ncbi.nlm.nih.gov/pubmed/33216822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27785
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados